High Hopes Ride on Cannabis Amid Opioid Crisis Jesse Ventura Is Fighting To Legalize Marijuana California expands marijuana rules, will allow deliveries Study: Cannabis users tend to be more successful, happy Cannabis could be a $5-billion boon to the state — but many users may stay illegal Rescheduling Marijuana: How it Works California could be a ‘sanctuary state’ from federal cannabis laws Older Women and Medical Cannabis: A Growth Industry France to Decriminalize Cannabis Possession, Interior Minister Says Epilepsy drug derived from marijuana is close to federal approval Vermont Governor Rejects Marijuana Bill, Wants Changes Marijuana App ‘WeGrow’ Wants To Bring Flower To The People States move fast to protect marijuana industry American Legion to Trump: Allow cannabis research for vets Washington law paves way for organic marijuana market Oregon Economic Forecast Includes Marijuana For The First Time No sanctuary for cannabis in California New Jersey mom turns marijuana into money Women have lead role in new marijuana businesses in Washington State Want to be a budtender? Here’s How. Marijuana May Boost, Rather Than Dull, the Elderly Brain Trump Rejects Congress as He Signals Medical Marijuana Fight The Cannabis Industry Is Getting Super-Sized 87% Of Players Say NFL Should Allow Medical Marijuana Access Pot brownies could lose potency under proposed California rules Cannabis Prices Get Higher After Recovering From 2016 Bust Study proves the importance of using Medical Cannabis The Trump crackdown on legal marijuana might not happen Varying marijuana laws pose questions for air travelers Marijuana – Miracle treatment for children with autism Marijuana workers get the California seal of approval Is Legal Marijuana the Last Bipartisan Cause in America? Marijuana activists vow to smoke and get arrested on steps of U.S. Capitol Most Americans Support Pro Athletes Using Marijuana for Pain Relief California Cannabis Is Going Industrial Trump’s drug czar pick has strong “no” vote record on marijuana Billions In Marijuana Taxes Are Addictive To State Governors The Holy Land of Medical Marijuana Oregon lawmakers vote to block cannabis users’ info from feds Marijuana legalization grows closer with Senate tax proposal Jerry Jones’s marijuana proposal could save NFL players’ lives The problem with America’s marijuana DUI laws John Oliver – Update Federal Marijuana Laws The way people buy legal marijuana will change in 2019 DOJ Wants Information On Colorado Marijuana Cases Oregon lawmakers introduce laws to protect legal recreational marijuana Public support for legal marijuana surged in 2016 Federal Marijuana Hostility Wrong Addiction Specialists Ponder a Potential Aid: Marijuana Dozens of industries could see a boost from legal marijuana Oregon May Declare Emergency Over Jeff Sessions’ Marijuana Threats Maximizing the Medical Effects of Marijuana Marijuana Legalization Opponents Were Wrong Oxford University announces new £10m medical marijuana research program Pro-marijuana church in Alabama: Members tout ‘God and cannabis’ Every State Could Legalize Marijuana by 2021- The Motley Fool 25% of US beer drinkers have switched to marijuana or would if it was legal Colorado Rep. Jared Polis has a plan to keep marijuana safe from Sessions Good science on marijuana is hard to find Jeff Sessions: Marijuana Is “Only Slightly Less Awful” Than Heroin Federal Marijuana Crimes Drop For Fifth Consecutive Year Jeff Sessions Will Enforce Federal Marijuana Laws In An ‘Appropriate Way’ Beer Industry Could Lose $2 Billion From Legal Marijuana Pot for pets: Owners treat sick animals with marijuana Marijuana Legalization Hasn’t Increased Traffic Fatalities Don’t let Big Marijuana prioritize profits over public safety The future of recreational marijuana in Trump’s America Idaho customers breathe life into tiny Oregon marijuana town Elizabeth Warren to Jeff Sessions “Respect state marijuana law” Doctors warn against teen pot use as marijuana laws loosen Will Edible And Concentrate Marijuana Brands Get As Big As Budweiser? Marijuana Industry To Create More Jobs Than Manufacturing By 2020 California Marijuana Is Not Safe to Smoke California marijuana tax and tracking systems behind schedule Republican Introduces “The Respect State Marijuana Laws Act” Why the Legal Marijuana Industry Is Suddenly Worried Military Veterans With PTSD Begin Marijuana Clinical Trials Marijuana Drug Could Extend Lives of Brain Cancer Patients, Study Finds Contaminated Medical Marijuana Believed To Have Killed California Cancer Patient Marijuana lobby goes mainstream Marijuana Prices Fall As Growers Flood The Market With Pot Scientists to Government: Make It Easier to Investigate Marijuana Likely scenarios for marijuana under Jeff Sessions as attorney general Six Predictions For The Marijuana Industry In 2017 Study finds traffic fatalities decline with medical marijuana laws This Company Is Using Brain Scans To Help You Select Medical Marijuana DEA dismissed its own misconceptions about marijuana Duke University Uses Identical Twins to Prove Weed Doesn’t Make Kids Dumb Marijuana industry brought to a standstill by pesticide testing problems Massachusetts Marijuana – Now What? Trump’s Attorney General Is a Bad Scenario for the Marijuana Industry Pharma executive behind OxyContin sells medical marijuana Marijuana Plants Flourish Under Energy-Saving LED Lights Legal Marijuana Could Drive A New Tech Boom California marijuana would fail Oregon’s standards, study finds When Medical Marijuana Is the Doctor’s Orders, Will Insurers Pay? Marijuana Sales Spike at Thanksgiving Legal marijuana users can’t legally buy a gun Maine marijuana legalization nears recount California marijuana industry is a ‘$25 billion opportunity’

Epilepsy drug derived from marijuana is close to federal approval

marijuana

epilepsy drug

An experimental epilepsy drug derived from cannabis to treat epilepsy is on the brink of becoming the first of its kind to win US government approval.

The epilepsy drug’s active ingredient is cannabidiol, the compound in marijuana thought to be responsible for many of its therapeutic effects. Cannabidiol doesn’t contain THC, marijuana’s main psychoactive ingredient, so it doesn’t get users high.

According to results from two large clinical trials released over the past two months, however, cannabidiol does appear to help reduce seizures in two of the hardest-to-treat forms of epilepsy, Lennox-Gastaut Syndrome and Dravet Syndrome.

If approved, the new epilepsy drug would be sold under the name Epidiolex as a syrup.

Because drugmaker GW Pharma was able to show that the product addresses a critical need, it was able to apply for a designation that could speed up the approval process. The company still faces some hurdles, though — the FDA has not yet approved any applications to sell marijuana for a health condition, and hasn’t given the green light to any drugs containing cannabidiol.

The first cannabidiol trial looked at the effects of the drug by studying 225 young people with Lennox-Gastaut Syndrome. The subjects were split into groups and given either a higher or lower dose of the epilepsy drug or a placebo for 14 weeks. The results, presented at the American Academy of Neurology’s yearly meeting in Boston, showed that participants in the higher-dose group saw their seizure occurrence drop by about 42%. Those given the lower dose saw a decrease of roughly 37%, and those given the placebo only saw a 17% reduction.

Epidiolex 100mg Carton Bottle (unenhanced) (0074c) (j10) Courtesy GW Pharma

The second trial, the results of which were published this week in the New England Journal of Medicine, looked at 120 children with Dravet syndrome. Half were given the drug and half received a placebo. Forty-three percent of participants given the drug saw their seizures reduced by half, and 5% stopped having seizures entirely. By comparison, the seizure rate in the group given a placebo barely budged.

Those promising findings build on previous research conducted last year by GW Pharma.

According to the Centers for Disease Control and Prevention, epilepsy affects more than 4.3 million Americans. Among these millions, however, various types and forms of the condition exist — and everyone reacts to treatments differently.

GW Pharma aims to submit its new drug application to the FDA by the middle of the year,  and is exploring treatments for various forms of the condition, though Epidiolex would treat only two specific types of the condition.

While Epidiolex could be the first cannabidiol-based drug to get FDA approval, the agency has already given the green light to two other drugs that contain components of cannabis: Marinol and Syndros are designed to treat anorexia using dronabinol, a synthetic form of THC.

More from businessinsider.com

Leave a Reply